Cortellini, Alessio <br/><br/>
Family history of cancer as surrogate predictor for immunotherapy with anti-PD1/PD-L1 agents: preliminary report of the FAMI-L1 study.  [electronic resource] 

 -  Immunotherapy  06 2018 
 - 643-655 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1750-7448 
<br/><br/><label>Standard No.: </label>10.2217/imt-2017-0167  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents, Immunological--therapeutic use<br/>B7-H1 Antigen--antagonists & inhibitors<br/>Female<br/>Humans<br/>Immunotherapy<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Neoplasms--drug therapy<br/>Neoplastic Syndromes, Hereditary--drug therapy<br/>Pilot Projects<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>Retrospective Studies<br/>Survival Analysis<br/>Treatment Outcome